U.S. Markets For Osteoporosis Management Products

Osteoporosis is a common metabolic bone disease that is characterized by the lossof bone mineral density (BMD).  Although the disease is not restricted to women, and many factors contribute to the cause of osteoporosis, the most significant factorfor women is menopause. Over the forecast period covered by this report, thenumber of women age 50 and older being treated for osteoporosis or osteopenia (i.e., low bone mass) is expected to increase at a compound annual rate of 5.4%,creating a significant market opportunity for osteoporosis management products. This report includes United States (U.S.) market forecasts for products that are used to diagnose and treat osteoporosis including bone densitometry systems, boneremodeling biochemical marker tests, and pharmaceutical treatments such ashormone replacement therapy (HRT) and osteoporosis drugs.